Page last updated: 2024-10-25

deferoxamine and Hepatitis, Animal

deferoxamine has been researched along with Hepatitis, Animal in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Hepatitis, Animal: INFLAMMATION of the LIVER in non-human animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wendel, A1
Tiegs, G1
Werner, C1

Other Studies

1 other study available for deferoxamine and Hepatitis, Animal

ArticleYear
Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice.
    Biochemical pharmacology, 1987, Aug-15, Volume: 36, Issue:16

    Topics: Allopurinol; Animals; Deferoxamine; Drug Interactions; Endotoxins; Galactosamine; Hepatitis, Animal;

1987